Tryp Therapeutics Inc. reported earnings results for the first quarter ended November 30, 2023. For the first quarter, the company reported net loss was CAD 1.16 million compared to CAD 1.63 million a year ago.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.06 CAD | 0.00% | +9.09% | +50.00% |
Mar. 08 | Tryp Therapeutics Inc. announced that it has received AUD 3.39 million in funding | CI |
Feb. 05 | Tryp Therapeutics Inc. Reports Earnings Results for the First Quarter Ended November 30, 2023 | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+50.00% | 4.24M | |
+1.77% | 42.86B | |
+47.70% | 41.36B | |
+12.24% | 42.74B | |
-8.83% | 27.68B | |
+7.44% | 25.15B | |
-23.01% | 18.63B | |
+30.56% | 12.37B | |
-1.82% | 11.92B | |
+8.35% | 11.21B |
- Stock Market
- Equities
- TRYP Stock
- News Tryp Therapeutics Inc.
- Tryp Therapeutics Inc. Reports Earnings Results for the First Quarter Ended November 30, 2023